The interactions of estrogens and progestins in producing decidualization , deciduosarcoma , and other lesions in the rabbit were explored. Steroids were delivered by silicone elastomer implants placed subdermally except for oral dosing in 1 experiment . Varying doses of levonorgestrel (LNG) were given with and without estradiol (E 2 ) and varying doses of E 2 with and without LNG. LNG alone delivered at an estimated mean dose of 233 l g/day did not result in endometrial decidualization or deciduosarcoma . Both conditions occurred when E 2 was added to the regimen and increased as the dose of E 2 was increased. Sixty l g of E 2 per day produced endometrial decidualization in all test animals in a 2-month exposure, but deciduosarcom a occurred only when LNG was also supplied and increased as the LNG dose was increased. Progesterone given with E 2 resulted in deciduosarcom a in most rabbits. Ethynylestradiol alone at 30 l g/day delivered by implants produced splenic and ovarian deciduosarcoma s in 1 of 5 test animals. Adding LNG resulted in more numerous and widespread deciduosarcomas . These experiment s indicate that exogenous estrogen is necessary for decidualization of the endometrium and to production of deciduosarcom a in the nonpregnan t rabbit. Exogenou s progestin promotes the process. Necrosis of the uterine wall tended to increase with increasing dose of estrogens.
INTRODUCTION
In 1987, Zook et al (10, 11) reported on the occurrence of malignant tumors, which they termed deciduosarcomas, in rabbits receiving levonorgestrel and estradiol by the vaginal route. The term re ects the fact that endometrial decidualization typically preceded the occurrence of overt tumors and that the tumor cells evidenced marked decidual morphology and features of malignancy. The deciduosarcomas were not, however, con ned to the uterus. They were found in the spleen in 7 of 23 animals and in other organs (liver, diaphragm, abdominal wall, and lungs) in 2 animals. In 2 of the rabbits with deciduosarcomas of the spleen, there was no corresponding tumor in the uterus, thus giving evidence that not all the extrauterine tumors arose by metastasis. There were, however, obvious pulmonary metastases in 4 of the 23 test rabbits.
This article describes the interplay of estrogens and progestins in eliciting the appearance of deciduosarcomas and other lesions. A companion paper (12) examines the duration of steroid treatment required for deciduosarcoma appearance, reversibility, and the extension of observations to castrated male rabbits.
METHODS

Animals
The rabbits used in these experiments were virgin New Zealand White females of about 6 months of age and weighing 3.2 to 4.7 kg. They were randomized into groups of 5 for dosing. The animals were housed in individual stainless steel cages in a room maintained at 18 2 C in an institution accredited by the Association for the Assessment and Accreditation of Laboratory Animal Care. An arti cial photoperiod of 12 hours of light and 12 hours of darkness was provided. Purina rabbit chow and tap water were provided ad lib.
Dosage Form
Steroids were delivered by subdermal implants or, in one case, by the oral route. Implants were placed subdermally in the animal's back near the neck using a sterile steel trocar for the insertion. Implants for LNG delivery incorporated the steroid in a rod-shaped core containing a mix of equal parts by weight of LNG and room-temperature-vulcanizable polydimethylsiloxane. The core was covered in turn by tubing of 0.2-mm wall thickness and formed from a dimethylsiloxane/methylvinylsiloxane copolymer. The ends of the rods were sealed with Silastic R polydimethylsiloxan e polymer. The overall diameter was 2.4 mm. The estimated dose of LNG is based on levonorgestrel loss from implants of the same type in women. These data indicate an average dose of 8.3 l g per cm implant length per day for the interval covered by the experiments reported here.
Implants containing E 2 were prepared by the same techniques using cores that contained 33% steroid. The release rate of E 2 is derived from in vitro release rates since data on loss of E 2 from implants in vivo are not available. Ethynylestradiol implants were also prepared by the same techniques. The core contained 50% steroid. The in vitro release rate was 28.5 l g/cm/day. Progesterone implants were covered rods of similar design with cores containing 33% progesterone. The in vitro release rate was 833 l g/cm/day. Because of the high release and early exhaustion of steroid supply, the progesterone implants were replaced at 20-day intervals.
Oral administration of steroids utilized the commercially available combination pill Lo Femenal R . Each tablet contains 30 l g of ethynylestradiol and 300 l g of norgestrel. 417 Norgestrel contains equal amounts of LNG and its inactive isomer. The pills were dispersed in 2 ml of water and administered intragastrically.
Estradiol was determined by radioimmunoassay using internal standards, ether extraction of serum, and dextrancoated charcoal to adsorb unbound steroid. LNG was determined by the Research Laboratory, University Hospital, Uppsala, Sweden by the radioimmunoassay procedures of Weiner et al. (8) except that tritium-labeled levonorgestrel was used as a tracer. The assay has an intra-assay coef cient of variation (CV) of < 5% and an interassay CV of 12% in the relevant concentration range.
At necropsy, lesions were noted and the weights of the uterus, liver, and spleen determined. Samples for tissue block preparation were taken from all lesions identi ed in organs or tissues, and samples were routinely taken from the uterus, spleen, lung, liver, and bone marrow. Tissues were xed in formalin, embedded in paraf n, sectioned, and stained with hemotoxylin and eosin. Histological examination was conducted by one of the authors (B.C.Z.). In some experiments, uterine luminal uid was collected for determination of uteroglobin concentrations by the methods of Torkkeli et al. (7) . Because uteroglobin is produced by epithelial cells and its synthesis and secretion are controlled by progestins (1, 7) , its concentration should re ect epithelial cell activity and the balance of progestin and estrogen effects on the endometrium.
RESULTS
Response to Varying Doses of Estradiol in the Presence of Levonorgestrel
An experiment was conducted in which a uniform dose of LNG (except in the placebo group) was administered together with varying doses of E 2 . Both drugs were delivered by subdermal implant. The experimental design together with mean concentrations of LNG and E 2 in serum, are indicated in Table 1 . Blood samples for circulating steroid concentrations were taken monthly. Necropsy was performed after 4.75 months of steroid administration.
Circulating LNG concentrations were highly similar among groups G to K and slightly lower in group L. Serum E 2 concentrations increased with increasing length of the estradiol-releasing implants, with a major increase occurring between groups I and J. a The standard deviation re ects the differences between animals with the entry for each animal being the mean of the 4 monthly readings for that animal.
b One animal died of an injury in the rst month.
The percentages of animals with uterine decidualization, deciduosarcoma in various organs, and uterine necrosis are indicated in Table 2 . Uterine decidualization was characterized by a focal, or sometimes diffuse, proliferation of large, highly vacuolated polygonal cells in the endometrium. When the decidual cells coalesced into masses with invasive characteristics, they were termed deciduosarcoma based on the rationale discussed by Zook et al (10) .
LNG alone produced neither decidualization of the uterine endometrium nor deciduosarcoma. Deciduosarcomas were concentrated in the three groups receiving doses of E 2 that increased circulating levels many-fold over basal levels, although one rabbit in Group I, in which E 2 levels were about twice as high as in the LNG-only group, developed desciduosarcoma. There were detectable effects at even the lowest dose of E 2 (Group H). Endometrial decidualization was evident in 2 of 5 animals in this group. Increased numbers of spindle-shaped cells in the mesenchyme of the spleen and decreased numbers of lymphoid follicles, which are known to precede deciduosarcomas (10) were found in 3 of 5 animals in this group. These changes were accentuated with increasing E 2 dose. At the highest E 2 doses (Groups K and L), necrosis and calci cation of the uterine wall occurred. In rabbits receiving the highest dose, observation of endometrial decidualization was not possible because massive necrosis and deciduosarcoma had obliterated the endometrium.
Uteroglobin concentrations in uterine uid as a function of steroid dose are shown in Figure 1 . Uteroglobin production was markedly increased by LNG administration. The stimulating effect of LNG on uteroglobin concentration was suppressed by E 2 in a dose-related manner.
Response to Varying Doses of LNG in the Presence of E 2
The relationship of LNG dose to the development of deciduosarcoma was explored using a constant high dose of estradiol and varying doses of LNG, both delivered by a Table 1 . F  0  0  0  0  0  0  0  0  0  G  0  233  0  0  0  0  0  0  0  H  2  233  40  0  0  0  0  0  0  I  6  233  40  0  20  0  0  0  0  J  20  233  100  0  100  40  20  0  0  K  60  233  100  75  100  75  25  0  25  L  200  233  ND b  100  100  100  40 40 20 a N 5 rabbits per group, one died of injury in group K and was excluded. b ND, not determined because of massive necrosis of uterus and occupation by deciduosarcoma precluded detailed study of endometrium. Table 3 . E 2 alone resulted in decidualization, but did not result in deciduosarcoma, nor were malignancies found when E 2 was supplemented with the lower doses of LNG, with one possible exception (an early atypical deciduosarcoma in one Group C rabbit). All animals in groups E and X, which received the highest doses of LNG, had multiple deciduosarcoma. Neoplastic decidual cells were found in the uterine blood vessels of many animals in groups E and X. Decidual changes in the uterus or spleen were observed in all animals except the control, which received no steriod. They were more marked in two groups that developed deciduosarcomas. Animals in all groups (except controls) evidenced decidual changes in the arteries of the uterus. Some decidual neoplasmas appeared to have arisen from the myometrial or mesometrial arteries rather than from the endometrium. No decidual reaction was observed in blood vessels outside the uterus or mesometrium. Necrosis of the uterine wall was common in all animals receiving estradiol. This reaction appeared somewhat modulated by the intermediate doses of LNG. 
Response With Progesterone as an Alternative Progestin
Included in the experiment with varying doses of LNG were 2 groups of rabbits receiving progesterone instead of LNG by implants. The doses delivered were estimated from in vitro measurements of progesterone release from implants. Findings are summarized in Table 4 . They show progesterone in combination with estradiol to be effective in stimulating deciduosarcoma in the rabbit.
Response With Ethynylestradiol as an Alternative Estrogen
In an additional experiment, ethynylestradiol was substituted for E 2 . Estimates of the doses delivered were based on measurements of in vitro release from the implants used. The experimental design and histological ndings are summarized in Table 5 . The implants were in place for 6 months before euthanasia of the animals. Ethynylestradiol alone was associated with deciduosarcomas in the spleen and ovary of one animal. In the presence of a high dose of LNG, even 10 l g/day of ethynylestradiol produced many deciduosarcomas. As in the experiments cited earlier, uterine necrosis and hyperplasia of splenic mesenchymal cells was seen in most animals in all groups receiving estrogen. Uterine necrosis was most extensive in the group receiving LNG and 30 l g/day of ethynylestradiol (5/5 animals vs 1/5 in the other 2 groups receiving steroids). Proliferation of hepatic bile ductules was observed in 40% of rabbits receiving ethynylestradiol. This lesion was not seen in any other test or in control rabbits.
Oral Administration
Evaluation of the effects of a typical oral combination contraceptive on deciduosarcoma in the rabbit was confounded by the very low bioavailability of ethynylestradiol in this species when given orally. Experiments were conducted in which LNG was delivered by oral pill and 30 l g of ethynylestradiol per day was delivered by implant. Measurement of LNG concentrations in serum showed the concentration at 3 hours to be half its 1-hour levels (1.3 ng/ml at 1 hour) and to be indistinguishabl e from zero at 24-hour postpill administration. The LNG exposure was therefore discontinuous. Drug administration was continued for 8 weeks. One animal out of 5 developed a deciduosarcoma in the spleen.
DISCUSSION
The results of this study extend the ndings of Zook et al (10) (11) (12) on production of deciduosarcomas in the rabbit by steroid administration. They show that the maximum appearance of deciduosarcoma resulted from high doses of both an estrogen and a progestin. When both progestin and estrogen were administered, the incidence of deciduosarcoma increased with increasing does of either (Tables 2 and 3 ). Because of the differing sacri ce times in the experiments represented by the 2 tables and the limited number of animals, strict quantitative comparisons are suspect but the principles involved clear. Deciduosarcoma were not found in any of the 5 animals receiving a high dose of LNG without exogenous estrogen or in any of the 5 receiving a high dose of LNG together with the lowest dose E 2 ( Table 2 ). Neither did LNG alone result in endometrial decidualization; however, only small doses of exogenous E 2 were required to stimulate decidualization in some animals ( Table 2 , Group H). A high dose of E 2 alone did not produce deciduosarcoma in any of 5 animals (Table 3) , but a high dose of ethynylestradiol resulted in a splenic deciduosarcoma in one of 5 animals (Table 5 ). High doses of estrogen resulted in endometrial decidualization whether or not LNG was also administered (Tables 3 and 5 ). Estrogen administration was also associated in a dose-related manner with cellular changes recognized to precede decidual neoplasms in the spleen.
The stimulation of stromal cells associated with estrogen dosing was accompanied by decreased prominence of epithelial cells as observed histologically (10) and as evidenced by attenuation of progestin stimulation of uteroglobin production (Figure 1 ).
Ethynylestradiol and the 2 highest doses of estradiol were associated with necrosis of the uterine wall. This lesion was reported by Zondek (9) in rabbits given prolonged large doses of "follicular narum." Ethynylestradiol administration was associated with proliferation of hepatic bile ductules. This lesion caused by ethynylestradiol has been previously observed in rabbits by one of us (BCZ) in an unpublishe d study.
Experiments conducted with progesterone or ethynylestradiol showed that the production of deciduosarcoma is not unique to either levonorgestrel or estradiol.
This study adds to evidence (10-12) that deciduosarcomas in the spleen are not dependent on metastasis from the uterus. In each of the studies (Tables 3, 4 , 5), there were instances of deciduosarcoma of the spleen in rabbits that had not developed uterine deciduosarcoma. The occurrence of tumors in the spleen without corresponding tumors in the uterus was especially prevalent in the group receiving the lower dose of progesterone (Table 4) .
Similarly to ndings in production of deciduosarcoma, benign endometrial decidualization depends on a combination of estrogen and progestin (2, 3) . The rabbit, however, seems to be extraordinarily sensitive to progression of the decidualization process to an invasive stage, as is described and discussed in a companion paper (12) . Although ectopic decidua occur fairly frequently in endometriotic tissue in women (4, 6), we have found no evidence in the literature of association between ectopic decidua and use of contraceptive containing estrogen/progestin combinations. Stromal tumors of the endometrium are extremely rare (5) .
